aTyr Pharma, Inc. (ATYR)
3.82
+0.13
(+3.52%)
USD |
NASDAQ |
Nov 20, 16:00
3.80
-0.02
(-0.52%)
After-Hours: 20:00
aTyr Pharma Total Assets (Quarterly) : 59.81M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 59.81M |
| June 30, 2026 | 69.82M |
| March 31, 2026 | 79.65M |
| December 31, 2025 | 94.16M |
| September 30, 2025 | 106.65M |
| June 30, 2025 | 101.53M |
| March 31, 2025 | 97.24M |
| December 31, 2024 | 98.05M |
| September 30, 2024 | 91.62M |
| June 30, 2024 | 105.94M |
| March 31, 2024 | 113.25M |
| December 31, 2023 | 122.07M |
| September 30, 2023 | 125.07M |
| June 30, 2023 | 132.75M |
| March 31, 2023 | 136.84M |
| December 31, 2022 | 95.79M |
| September 30, 2022 | 96.06M |
| June 30, 2022 | 96.02M |
| March 31, 2022 | 104.78M |
| December 31, 2021 | 115.54M |
| September 30, 2021 | 123.92M |
| June 30, 2021 | 49.00M |
| March 31, 2021 | 55.13M |
| December 31, 2020 | 38.73M |
| Date | Value |
|---|---|
| September 30, 2020 | 41.64M |
| June 30, 2020 | 47.56M |
| March 31, 2020 | 54.45M |
| December 31, 2019 | 36.19M |
| September 30, 2019 | 43.74M |
| June 30, 2019 | 48.76M |
| March 31, 2019 | 49.92M |
| December 31, 2018 | 52.75M |
| September 30, 2018 | 59.77M |
| June 30, 2018 | 68.31M |
| March 31, 2018 | 78.47M |
| December 31, 2017 | 89.36M |
| September 30, 2017 | 94.49M |
| June 30, 2017 | 61.47M |
| March 31, 2017 | 65.74M |
| December 31, 2016 | 80.52M |
| September 30, 2016 | 85.92M |
| June 30, 2016 | 100.49M |
| March 31, 2016 | 115.12M |
| December 31, 2015 | 129.68M |
| September 30, 2015 | 141.37M |
| June 30, 2015 | 153.08M |
| March 31, 2015 | 59.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.01M |
| Shareholders Equity (Quarterly) | 33.98M |
| Debt to Equity Ratio | 0.3213 |
| Current Ratio | 3.047 |
| Net Debt Paydown Yield | 1.16% |